Episode 96: The TREAT-MS Clinical Trial (and why it’s so important) with Dr. Ellen Mowry

Episode 96: The TREAT-MS Clinical Trial (and why it’s so important) with Dr. Ellen Mowry

Publication date: Jul 01, 2019

Do you ever wonder how or why your neurologist recommends one disease-modifying therapy instead of another? For some people, their first disease-modifying therapy is a mild drug with few side effects. For others, their first disease-modifying therapy might be a more high-powered drug that carries the risk of more possible side effects. But how do neurologists really know when it’s appropriate to use one specific disease-modifying therapy or even when it’s appropriate to switch to another? My guest is Dr. Ellen Mowry, Associate Professor of Neurology and the Director of the MS Experimental Therapeutics Program at Johns Hopkins University. Dr. Mowry has devoted her entire career to MS research, and her past research has led to breakthroughs in our understanding of MS. Now, Dr. Mowry is the co-principal investigator of a nationwide research study whose outcome could have an impact on the treatment strategy for everyone diagnosed with MS. We’re also talking about the effectiveness of the Wahls Diet in managing MS fatigue, we’ll update you on the permanent injunction issued by a U.S. Federal Court against a company that operates shady stem cell clinics, and you’ll learn everything you really need to know about Vitamin D and MS. We have a lot to talk about. Are you ready for RealTalk MS??! NEW! Download a transcript of this episode! ___________ Like to Read? Now You Can Download a Transcript of Every New Episode of RealTalk MS :26 The Wahls Diet (Plus Lots of Other Interventions) May Reduce MS Fatigue 2:17 U.S. District Court Judge Prevents U.S. Stem Cell From Extracting Stem Cells From Your Fat And Claiming That It Will Be Of Any Benefit To You 7:22 My Interview with Dr. Ellen Mowry 13:46 Have You Subscribed to RealTalk MS? 33:02 ___________ ADD YOUR VOICE TO THE CONVERSATION I’ve always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts! Email: jon@realtalkms.comPhone: (310) 526-2283 ___________ LINKS If your podcast app doesn’t allow you to click on these links, you’ll find them in the show notes in the RealTalk MS app or at www.RealTalkMS.com TREAT-MS on clinicaltrials.gov STUDY: Lipid Profile is Associated with Decreased Fatigue in Individuals with Progressive Multiple Sclerosis Following a Diet-Based Intervention: Results from a Pilot Study FDA Statement on Stem Cell Clinic Permanent Injunction and FDA’s Ongoing Efforts to Protect Patients from Risks of Unapproved Products Download the RealTalk MS App for iOS Download the RealTalk MS App for Android Give RealTalk MS a Rating & Review NEW! Download a Transcript of This Episode ___________ Follow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com. RealTalk MS Episode 96 Hosted By: Jon Strum Guest: Dr. Ellen Mowry Tags: MS, MultipleSclerosis, MSResearch, HopkinsMedicine, terrywahls, US_FDA, RealTalkMS

Concepts Keywords
African American Fatigue
Alcohol Terminal diseases
Android Parkinson’s disease
Apologize Arthritis
Arthritis Food
AtT Dairy products
Autopsy Oil
Blood Study protocol
Body Mass Stem cell products
Brain Obesity
Brisk Multiple sclerosis
California MS
Caucasian M S fatigue
Cholesterol Neurologic symptoms
Clinical Trial Chronic conditions
Clinical Trials Serious diseases
Cohort Visual dysfunction
Coin Flip MS fatigue
Control Group Erectile dysfunction
Cross Specific disease
Dairy Massage
Disability Meditation
Drug Side Effects Branches of biology
Eggplant Nutrients
Emery Health
Equator Vitamins
Erectile Dysfunction Nutrition
Escalator Biomolecules
Espresso Secosteroids
Extra Time Sun tanning
Fat Vitamin D
Fatigue Multiple sclerosis
Fatty Acids Stem-cell therapy
FDA Study protocol
Federal Court Tomography
Fish Stem Cells
Gay Android
Georgetown University Cellular telephone
Gluten
Green Leafy Vegetables
Hanged
Hard News
Harp
HDL Cholesterol
Heterogeneity
Hot Topic
Injunction
Insurance
IOS
Iowa
Johns Hopkins University
Latino
LDL Cholesterol
Lentils
Lesion
Lipid
Maine
Maori
Marius
Massage
Meat
Medicine
Meditation
Morbidity
Multiple Sclerosis
Muscle
Neurologist
Neurology
Oats
Obesity
Optical Coherence Tomography
Oven
Overtime
Parkinson
Pennsylvania
Permanent Injunction
Physical Activity
Physical Exercise
Pike
Podcast
Principal Investigator
Progressive
Protocol
Recommended Daily Allowance
Relapse
Rice
Riding
San Francisco
Smoking
Snake Oil
Soft Launch
Stronger
Sugar
Symptom
Thes
Treaty
Tree
Triglycerides
Twitter
Ultraviolet Light
United States
Vitamin
War
Wheat
Wheelchair

Semantics

Type Source Name
gene UNIPROT EHD1
gene UNIPROT SMIM10L2B
gene UNIPROT SMIM10L2A
gene UNIPROT IMPACT
drug DRUGBANK Vitamin D
drug DRUGBANK Palmitic Acid
gene UNIPROT FAT1
gene UNIPROT CD36
gene UNIPROT CHL1
gene UNIPROT APP
drug DRUGBANK Coenzyme M
disease MESH Multiple Sclerosis
disease DOID Multiple Sclerosis
gene UNIPROT EGR3
drug DRUGBANK Methyltestosterone

Similar

Original Article

Leave a Comment

Your email address will not be published. Required fields are marked *